The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia
Article in Frontiers in Pharmacology (November 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review
Article in Value in Health (March 2022)
Synthetic long-acting insulin analogs for the management of type 1 diabetes: an update
Article in Expert Opinion on Pharmacotherapy (September 2021)